首页 正文

Depemokimab-ulaa: A Long-Acting Interleukin-5 Inhibitor

{{output}}
Objective: To review the pharmacology, efficacy, and safety of subcutaneous depemokimab-ulaa as add-on therapy in the treatment of severe eosinophilic asthma. Dat... ...